Transitional Treatment of Adolescents in Family Therapy
NCT ID: NCT00680381
Last Updated: 2014-08-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
90 participants
INTERVENTIONAL
2004-01-31
2014-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Adolescent Substance Abuse: Progressive Treatment
NCT00680576
Development of a Family-Based Treatment for Adolescent Methamphetamine Use
NCT00680511
Brief Strategic Family Therapy for Adolescent Drug Abusers
NCT00095303
Family Therapy Via Video Teleconference for Substance-Abusing Rural Adolescents
NCT01751217
Family and Adolescent Motivational Incentives for Leveraging Youth
NCT01736995
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Following 12 weeks of Functional Family Therapy (FFT), semi-weekly therapist phone calls for eight weeks.
MTI, Minimal Transitional Intervention
Following 12 weeks of Functional Family Therapy (FFT), semi-weekly phone calls from a therapist for eight weeks.
2
Following 12 weeks of FFT, weekly one-hour group therapy for eight weeks
GTI, Group Transitional Intervention
Following 12 weeks of FFT, weekly one-hour sessions of group therapy for eight weeks.
3
Following 12 weeks of FFT, an eight-week, customized series of therapist visits with the adolescent, family, teachers, coaches and others who can support the adolescent's reduced level of drug use.
STI, Systems Transitions Intervention
Following 12 weeks of FFT, an individualized eight-week series of therapist meetings with the adolescent, family, police, teachers, coaches and others who can support the adolescent's reduced drug use.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MTI, Minimal Transitional Intervention
Following 12 weeks of Functional Family Therapy (FFT), semi-weekly phone calls from a therapist for eight weeks.
GTI, Group Transitional Intervention
Following 12 weeks of FFT, weekly one-hour sessions of group therapy for eight weeks.
STI, Systems Transitions Intervention
Following 12 weeks of FFT, an individualized eight-week series of therapist meetings with the adolescent, family, police, teachers, coaches and others who can support the adolescent's reduced drug use.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. 13 to 18 years if age
3. meets DSM-IV (APA, 1994) diagnostic criteria for substance abuse or dependence
4. Lives in the Albuquerque metropolitan area or surrounding communities with a parent, step-parent, or surrogate parent; AND
5. Sufficient residential stability to permit probable contact at follow-up (e.g., not homeless at time of intake).
Exclusion Criteria
2. Adolescent deemed dangerous to self or others during evaluation
3. Services other than outpatient treatment required for the adolescent (e.g., inpatient, detoxification)
4. Adolescent already has participated in treatment project at CFAR; AND
5. A sibling is already participating in project.
13 Years
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oregon Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Holly B. Waldron, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Oregon Research Institute Center for Family and Adolescent Research (ORI/CFAR)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oregon Res. Inst. Center for Family & Adolescent Research (CFAR)
Albuquerque, New Mexico, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DA15762
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.